Cargando…
Matrix‐assisted laser desorption ionization ‐ mass spectrometry imaging of erlotinib reveals a limited tumor tissue distribution in a non‐small‐cell lung cancer mouse xenograft model
Autores principales: | Kim, Tae Young, Lee, Boram, Kim, Yonghyo, Sugihara, Yutaka, Rezeli, Melinda, Szasz, A. Marcell, Dome, Balazs, Marko‐Varga, Gyorgy, Kwon, Ho Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265169/ https://www.ncbi.nlm.nih.gov/pubmed/34323418 http://dx.doi.org/10.1002/ctm2.481 |
Ejemplares similares
-
Challenging the heterogeneity of disease presentation in malignant melanoma—impact on patient treatment
por: Marcell Szasz, A., et al.
Publicado: (2018) -
Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
por: Sugihara, Yutaka, et al.
Publicado: (2018) -
DNA Polymerase Alpha Subunit B Is a Binding Protein for Erlotinib Resistance in Non-Small Cell Lung Cancer
por: Kim, Tae Young, et al.
Publicado: (2020) -
Proteomic analysis enables distinction of early‐ versus advanced‐stage lung adenocarcinomas
por: Kelemen, Olga, et al.
Publicado: (2020) -
Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging
por: Nishimura, Meiko, et al.
Publicado: (2018)